Show simple item record

dc.contributor.authorDe Nardi, Andrigo Barbozapt_BR
dc.contributor.authorGerardi, Daniel Guimarãespt_BR
dc.contributor.authorDagli, Maria Lucia Zaidanpt_BR
dc.date.accessioned2022-04-13T04:50:25Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn2073-4409pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/237072pt_BR
dc.description.abstractMast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the 2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofCells. Basel. Vol. 11, no. 4 (Feb. 2022), 618, 37 p.pt_BR
dc.rightsOpen Accessen
dc.subjectMast cell tumoren
dc.subjectMastocitoma cutâneopt_BR
dc.subjectCutaneousen
dc.subjectDiagnósticopt_BR
dc.subjectTratamentopt_BR
dc.subjectSubcutaneousen
dc.subjectPrognósticopt_BR
dc.subjectDogen
dc.subjectCãespt_BR
dc.titleDiagnosis, prognosis and treatment of canine cutaneous and subcutaneous mast cell tumorspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001138055pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record